Home › Funds › Tyro Capital Management LLC › TRVI

Tyro Capital Management LLC position in TRVI

TREVI THERAPEUTICS INC · Health Care

Tyro Capital Management LLC reported holding 291,890 shares of TRVI (TREVI THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.74% of its reported portfolio and ranking #24 among its reported holdings. Tyro Capital Management LLC first reported this position in Q3 2026.

Latest position (Q3 2026)291.89K sh
Reported value held$4.18M
Portfolio Weight0.74%
First reportedQ3 2026
Last changeNew
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Tyro Capital Management LLC's TRVI position evolved

Tyro Capital Management LLC first disclosed a stake in TRVI in Q3 2026 at 291,890 shares (US$4.2M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 291.89K $4.18M New

About TRVI and 13F data

TRVI (TREVI THERAPEUTICS INC) is a Health Care company. 65 other funds we track also report a position in TRVI — the largest reported positions include NEA Management Company, LLC (US$246.6M), Frazier Life Sciences Management, L.P. (US$185.4M), Vivo Capital, LLC (US$95.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TRVI

All TRVI fund holders →

FAQ

How long has Tyro Capital Management LLC held TRVI?

Tyro Capital Management LLC has disclosed TRVI holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Tyro Capital Management LLC's current position in TRVI?

As of Q3 2026, Tyro Capital Management LLC holds 291.89K shares of TRVI (TREVI THERAPEUTICS INC), valued at $4.18M, representing 0.74% of its reported portfolio and ranking #24.

Has Tyro Capital Management LLC been buying or selling TRVI?

In the latest 13F filing (Q3 2026), Tyro Capital Management LLC newly opened its position in TRVI.

Which other funds hold TRVI?

Other major institutional holders of TRVI include NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Vivo Capital, LLC, among 65 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.